Key facts
- This page summarizes Patrick D. Spangler's Form 4 filing for OptimizeRx Corp (OPRX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Apr 2022, 16:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
Footnote F2
The restricted stock units vest on March 30, 2023.
SEC remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.